1Thompson RH,Boorjian S A,Lohse C M,et al.Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy[J].J Urol,2008,179 (2):468,discussion 472.
2Flanigan RC,Mickisch G,Sylvester R,et al.Cytoreductive nephrectomy in patients with metastatic renal cancer; A combined analysis[J].J Urol,2004,171:1071.
3Flanigan RC,Salmon SE,Blumenstein BA,et al.Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer[J].N Engl J Med,2001,345:1655.
4Mickisch GH,Garin A,van Poppel H,et al.Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma:A randomized trial[J].Lancet,2001,358:966.
5Rouviere O,Bouvier R,Negrier S,et al.Nonmetastatic renal cell carcinoma:Is it really possible to define rational guidelines for post treatment follow up[J].Nat Clin Pract Oncol,2006,3:200.
6Messing EM,Manola J,Wilding G,et al.Phase Ⅲ study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma:An Estern Cooperative Oncology Group/Intergroup trial[J].J Clin Oncol,2003,21:1214.
7Negrier S,Escudier B,Lasset C,et al.Recombinant human interleukin-2,recombinant human interferon alfa-2a,or both in metastatic renal-cell carcinoma[J].N Engl J Med,1998,338:1273.
8Yang JC,Sherry RM,Steinberg SM,et al.Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cacer[J].J Clin Oncol,2003,21:3127.
9Motzer RJ,Hutson TE,Tomczak P,et al.Sunitinib versus interferon alfa in metastatic renal-cell carcinoma[J].N Engl J Med,2007,356:115.
10Motzer RJ,Basik J,Murphy BA,et al.Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma[J].J Clin Oncol,2002,20:289.
8Krieg M,Haas R,Brauch H.Up regulation of hypoxia inducible factors HIF 1 alpha and HIF 2 alpha under normoxic conditions in renal carcinoma cells by yon HippeI-Lindau tumorsuppressor 8ene losg of function[J]. Oncogene, 2000,19(48): 5435-5443.
9Turner KJ,Moore JW,Jones A.Expression of hypoxia inducible factors in human renal cancer,relationship to angiogenesis and to the yon Hippel- Lindau gene mutation [J]. Cancer Ies, 2002,62(10): 2957-2961.
10Escudier B,Eisen T,Stadler WM,et aI.So rafenib in advanced clear-cell renal carcinoma[J]. N Engl J Med, 2007,356(2). 125-134.
